Female Sexual Health: Screening and Evaluation
- PMID: 38777480
- DOI: 10.1016/j.ogc.2024.03.002
Female Sexual Health: Screening and Evaluation
Abstract
Female sexual dysfunction is highly prevalent, affecting 30% to 50% of cisgender women globally. Low sexual desire, sexual arousal disorder, and orgasm disorder affect 10% to 20%, 6% to 20%, and 4% to 14% of women, respectively. Dyspareunia or pain with intercourse affects 8% to 22% of women. Universal screening is recommended; and a thorough medical history and physical examination are the foundations of evaluation and assessment. Laboratory tests and imaging are sometimes warranted, but referral to a sexual medicine expert is suggested if the practitioner is unfamiliar or uncomfortable with treatment.
Keywords: Female orgasm disorder; Female sexual arousal disorder; Hypoactive sexual desire disorder; Screening sexual problems; Sexual dysfunction; Sexual pain.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure S.J. Parish serves as a consultant for Dare Bioscience and received no funding for this article. R. Pope serves as a speaker for Astellas, a consultant for Johnson and Johnson Global Public Health, Materna MD, Mim, and Stardust, and received no funding for this article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
